spacer
home > pmps > autumn 2017 > industry insight
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Industry Insight

Many of the manufacturing processes used for the production of medicines are pretty much the same today as they were when I began my professional career over 30 years ago. This is not necessarily due to a lack of advances in manufacturing technologies that could benefit the industry. To a large extent, the inertia for adopting alternative manufacturing technologies relates to the industry fearing rejection from the regulatory authorities for introducing such changes, which is unfounded. The value of the global pharmaceutical market is estimated to be worth over $500 billion annually, therefore improvements to manufacturing efficiencies could certainly pay dividends to companies in maximising the ‘profit’ to ‘cost of goods’ ratio.

Things are changing. The regulatory organisations are encouraging pharma manufacturers to invest in and exploit advanced manufacturing technologies, and the FDA has created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing (1,2).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Robert Harris, Chief Technical Officer at Juniper Pharma Services, PMPS Industry Advisor
spacer
Robert Harris
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Clinical Services Announces Launch of a Mobile App for its Comprehensive Customer Support Portal Webflow™

Philadelphia, USA – 15 November 2017. PCI has today announced the launch of a mobile application (app) to provide more convenient access to its client services online portal Webflow™. Webflow™ is a comprehensive customer support center which provides PCI clients real-time, 24/7 access to a wide range of reports and information regarding the status of their Clinical Trial supplies across all PCI Clinical Services sites in Europe and North America. The new free app, available on Android and Apple iOS, is designed to provide even more flexible access to the Webflow™ offering – enabling customers efficient and effective on demand supply chain management to meet the ever-changing requirements of global trials.  
More info >>

White Papers

Exploring Protein Stability by nanoDSF

NanoTemper Technologies GmbH

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
More info >>

 
Industry Events

13th Annual Biomarkers Congress

15-16 February 2018, Manchester Central Convention Complex, Manchester, UK

Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018, Manchester. The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement